TipRanks
Bicycle Therapeutics Ltd (DE:50BA)
FRANKFURT:50BA
Germany Market
50BA
Bicycle Therapeutics
RESEARCH TOOLSreports

Bicycle Therapeutics (50BA) Income Statement

1 Followers

Bicycle Therapeutics Income Statement

Last quarter (Q2 2026), Bicycle Therapeutics's total revenue was $629.00K, a decrease of -78.46% from the same quarter last year. In Q2, Bicycle Therapeutics's net income was $-50.33M. See Bicycle Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.59M$ 35.27M$ 26.98M$ 14.46M$ 11.70M
Gross Profit
$ 72.59M$ -137.69M$ -129.52M$ 14.46M$ 11.70M
Operating Expenses
$ 320.30M$ 72.18M$ 60.43M$ 131.12M$ 77.31M
Depreciation and Amortization
$ 6.42M$ 7.18M$ 6.55M$ 3.69M$ 1.41M
EBITDA
$ -212.18M$ -164.89M$ -169.40M$ -107.21M$ -64.09M
Operating Income
$ -247.72M$ -209.87M$ -189.95M$ -116.65M$ -65.62M
Other Income/Expenses
$ 28.91M$ 36.08M$ 10.74M$ 2.41M$ -2.86M
Pretax Income
$ -218.81M$ -173.80M$ -179.21M$ -114.24M$ -68.48M
Net Income
$ -218.96M$ -169.03M$ -180.66M$ -112.72M$ -66.82M
Per Share Metrics
Basic EPS
$ -3.16$ -2.91$ -5.08$ -3.80$ -2.67
Diluted EPS
$ -3.16$ -2.90$ -5.08$ -3.80$ -2.67
Weighted Average Shares Outstanding
 69.28M 58.21M 35.59M 29.66M 25.06M
Weighted Average Shares Outstanding (Diluted)
 69.28M 58.21M 35.59M 29.66M 25.06M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History